|Bid||15.20 x 100|
|Ask||15.75 x 300|
|Day's range||15.66 - 15.91|
|52-week range||10.86 - 19.09|
|PE ratio (TTM)||43.82|
|Earnings date||19 Mar 2018 - 23 Mar 2018|
|Forward dividend & yield||N/A (N/A)|
|1y target est||19.84|
Canadian Solar (CSIQ) not only boasts strong prospects in China, its business operations is widely spread across the globe as well.
Canadian Solar (CSIQ) witnessed solid year-over-year improvement in its third-quarter revenue as well as gross margin figures.
Shares of Canadian Solar (CSIQ) are higher on Tuesday, a day after its CEO offered to take it private for $18.47 a share. Today, JPMorgan's Paul Coster and his team downgraded the stock to Underweight from Neutral, although they maintained their $15 price target, arguing that the offer will cap the stock near term. Coster writes that investors shouldn't short the stock, but he now expects it to underperform other solar stocks in his coverage in the near-term. From his note: We do not believe a higher, competing offer is likely and there could still be risks associated with the deal itself.
Several major solar energy stocks, including SolarEdge Technologies (SEDG) and SunPower Corporation (SPWR), surged on Monday morning after Canadian Solar's (CSIQ) CEO announced his plan to take the company private.
Shares of Canadian Solar (CSIQ) are surging over 5% after CEO Shawn Qu offered to take the company private in a deal valued at at $1.07 billion. BioMarin Pharmaceutical (BMRN) is on the rise after announcing updates on an investigational gene therapy treatment for severe hemophilia. SunTrust Robinson Humphrey analyst Edward Nash raised his price target on the stock to $130.00. Monsanto (MON) shares are in focus as the seed and agro chemical giant will give cash back to US farmers who buy its weed killer XtendiMax with VaporGrip, which has been linked to crop damage.
Solar stocks are higher Monday, following upgrades and an offer to take Canadian Solar (CSIQ) private. Canadian Solar Chairman and CEO Dr. Xiaohua (Shawn) Qu said he wants to take the company private in a non-binding proposal at $18.47 a share, some 7% above its Friday close. Dr. Qu and his wife are the largest shareholders in the company, with just under a quarter of the diluted common shares outstanding.
Canadian Solar's (CSIQ) latest project has the capability to identify and secure high quality development opportunities in Japan's competitive solar market.
The sale of 99% stake in the 92 megawatt-peaks (MWp) IS-42 solar project to Falck Renewables S.p.A is expected to expand Canadian Solar's (CSIQ) footprint in the United States.
The two new solar projects to be constructed by Canadian Solar (CSIQ) diversify its portfolio of under-construction or operating assets across 18 prefectures throughout Japan.
For 3Q17, analysts expect Yingli Solar to report a gross profit of nearly $3.0 million with a gross margin of nearly 1.2%.
In an attempt to contribute to the government's goal of increasing electricity generated from clean energy sources, Canadian Solar (CSIQ) will be building solar power projects in Mexico.
On September 30, 2017, Canadian Solar (CSIQ) reported ~$1.2 billion in cash, cash equivalents, and restricted cash.
Canadian Solar's (CSIQ) operating income for 3Q17 was ~$57.8 million, compared to $83.7 million in 2Q17 and $27.0 million in 3Q16.
Canadian Solar’s (CSIQ) total operating expenses totaled ~$102.0 million in 3Q17 compared to $84.1 million in 2Q17 and $90.3 million in 3Q16.
Canadian Solar (CSIQ) reported its 3Q17 earnings results on November 9. CSIQ declared earnings per share of $0.22, slightly below the analyst consensus estimate of $0.26.